Format

Send to

Choose Destination
Am J Neurodegener Dis. 2012;1(1):15-31. Epub 2012 May 15.

Proteolytic processing of the prion protein in health and disease.

Author information

1
Institute of Neuropathology, University Medical Center Hamburg-Eppendorf Hamburg, Germany.

Abstract

A variety of physiological functions, not only restricted to the nervous system, are discussed for the cellular prion protein (PrP(C)). A prominent, non-physiological property of PrPC is the conversion into its pathogenic isoform (PrP(Sc)) during fatal, transmissible, and neurodegenerative prion diseases. The prion protein is subject to posttranslational proteolytic processing and these cleavage events have been shown i) to regulate its physiological functions, ii) to produce biologically active fragments, and iii) to potentially influence the course of prion disease. Here, we give an overview on the proteolytic processing under physiological and pathological conditions and critically review what is currently known about the three main cleavage events of the prion protein, namely α-cleavage, β-cleavage, and ectodomain shedding. The biological relevance of resulting fragments as well as controversies regarding candidate proteases, with special emphasis on members of the A-disintegrin-and-metalloproteinase (ADAM) family, will be discussed. In addition, we make suggestions aimed at facilitating clarity and progress in this important research field. The better understanding of this issue will not only answer basic questions in prion biology but will likely impact research on other neurodegenerative diseases as well.

KEYWORDS:

ADAM10; ADAM17; Prion protein; ectodomain shedding; proteolytic processing; α-cleavage; β-cleavage

PMID:
23383379
PMCID:
PMC3560451

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center